| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002188A1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 01/22/1998 | WO1998002187A1 Pharmaceutical composition containing acid addition salt of basic drug |
| 01/22/1998 | WO1998002186A1 Inclusion complex containing indole selective serotonin agonist |
| 01/22/1998 | WO1998002178A1 Methods of controlling axonal growth |
| 01/22/1998 | WO1998002160A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 01/22/1998 | WO1998002158A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 01/22/1998 | WO1998002152A1 Pharmaceutical compositions comprising s-(-)-n-propargyl-1-amino indan |
| 01/22/1998 | WO1998002148A2 Pharmaceutical composition |
| 01/22/1998 | CA2295500A1 Methods of controlling axonal growth |
| 01/22/1998 | CA2260269A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | CA2259418A1 Pharmaceutical composition containing acid addition salt of basic drug |
| 01/22/1998 | CA2257860A1 Inclusion complex containing indole selective serotonin agonist |
| 01/22/1998 | CA2255073A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 01/21/1998 | EP0819760A1 Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
| 01/21/1998 | EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use |
| 01/21/1998 | EP0819438A2 Buprenorphine percutaneous absorption preparation |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0819126A1 Biphenylamide derivatives as 5ht 1d? antagonists |
| 01/21/1998 | EP0819113A1 Benzamides for neurodegenerative disorder treatment |
| 01/21/1998 | EP0819005A1 2-acylaminopropanamides as tachykinin receptor antagonists |
| 01/21/1998 | EP0819002A1 USE OF IMIDAZOL 1,2-a]PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA |
| 01/21/1998 | EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
| 01/21/1998 | EP0818999A1 Pharmaceutical agents for the treatment of alzheimer's disease |
| 01/21/1998 | EP0625977B1 Piperazine derivatives as 5-ht1a antagonists |
| 01/21/1998 | EP0594636B1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1998 | EP0527917B1 Use of adenosine and adenosine derivatives for anesthesia |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171118A Fibronectin adhesion inhibitors |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171114A Androstane and preg nane series for allosteric modulation of gamma-amino-butyric acid receptor |
| 01/21/1998 | CN1170574A Sulfonamides and their use |
| 01/20/1998 | US5710274 N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands |
| 01/20/1998 | US5710169 Therapeutic heterocycles |
| 01/20/1998 | US5710151 Method of treating urinary bladder dysfunctions |
| 01/20/1998 | US5710149 Piperazine derivatives as 5-ht antagonists |
| 01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
| 01/20/1998 | US5710139 Heterocyclic compounds |
| 01/20/1998 | US5710138 Benzo f!quinoxalinedione derivatives, their production and use in pharmaceutical agents |
| 01/20/1998 | US5709869 Intradermal delivery of lidocaine |
| 01/19/1998 | CA2210613A1 N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use |
| 01/19/1998 | CA2210597A1 Buprenorphine percutaneous absorption preparation |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | WO1998001425A1 1,4-di-sustituted piperidines as muscarinic antagonists |
| 01/15/1998 | WO1998001157A1 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
| 01/15/1998 | WO1998001149A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | WO1998001124A2 Pharmaceutical preparation containing nimesulide for topical use |
| 01/15/1998 | WO1998001118A1 Pharmaceutical composition for oral delivery |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | DE19646977A1 Stable dry extract of Hypericum perforatum L., Saint John's wort |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/15/1998 | CA2259010A1 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
| 01/14/1998 | EP0818449A1 2-(1H)-quinolone derivatives as antagonists of excitatory amino acids |
| 01/14/1998 | EP0817969A1 Inhibition of tau-tau-association |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817769A1 Novel borneol esters, process for their preparation and their pharmaceutical use |
| 01/14/1998 | EP0817767A1 Bicyclic amine derivatives and their use as anti-psychotic agents |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0817621A1 Pharmaceutical composition for transdermic delivery |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0660832B1 Serotonin receptor agents |
| 01/14/1998 | EP0642336B1 Use of nsiad in the treatment of dementia |
| 01/14/1998 | EP0603301B1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 01/14/1998 | EP0565732B1 Benzodioxane derivative |
| 01/14/1998 | CN1170435A Regulation of neural stem cell proliferation |
| 01/14/1998 | CN1170434A In vitro Induction of dopaminergic cells |
| 01/14/1998 | CN1170405A Aryl-and hetaryl-sulfonamide derivatives, their perparation and their use as endothelin antagonists |
| 01/14/1998 | CN1170367A Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 01/14/1998 | CN1170365A Use of £R-(Z)|-alpha-(methoxyimino)-alpha-£1-azabicyclw £2. 2. 2| oct-3-yl) acetonitrile to reduce amyloid beta A4 formation in Alzheimers disease |
| 01/14/1998 | CN1169994A Xanthine compounds having terminally aminated alkynol side chains |
| 01/14/1998 | CN1169875A Oral liquid of Chinese medicine for deficiency syndrome |
| 01/14/1998 | CN1036995C Imidazodiazepine, and its preparation and use |
| 01/13/1998 | US5708171 Imidazole derivatives for pharmaceutical use |
| 01/13/1998 | US5708033 Antiinflammatory agents, antiarthritic agents or analgesics |
| 01/13/1998 | US5708026 Cyclohexane derivatives |
| 01/13/1998 | US5708020 Arylalkyl(thio)amides |
| 01/13/1998 | US5708018 2-aminoindans as selective dopamine D3 ligands |
| 01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |
| 01/13/1998 | US5708015 Method for using pharmaceutical compositions containing 2-(2-alkyphenyl-amino)-thiazolines as adrenergic agents |
| 01/13/1998 | US5708014 Method for treating anxiety |
| 01/13/1998 | US5708011 Use of levobupivacaine in a patient having depressed myocardial contractility |
| 01/13/1998 | US5708008 Treatment of migraine |
| 01/13/1998 | US5708007 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) benzofuran-7-ol and carbamate derivatives for treating memory dysfunction |
| 01/13/1998 | US5707991 N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin |
| 01/13/1998 | US5707988 Anxiolytic agents, cognition activators |